Blockchain in Genomics Market - Industry Report & Forecast 2029

A quick peek into the report

Report Description

The global blockchain in genomics market research report provides a holistic view of the market in terms of various factors influe

Scope of the Market Intelligence on Global Blockchain in Genomics Market

The global blockchain in genomics market research report provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the blockchain-based products and services allied with the genomics market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect global blockchain in genomics market.

Market Segmentation

The global blockchain in genomics market segmented on the basis of business model, service, application, end user, and region.

The global blockchain in genomics market segmentation (on the basis of business model) is further segmented into B2B, B2C, and C2B.

The global blockchain in genomics market segmentation (on the basis of service) is further segmented into blockchain platforms and utility tokens.

The global blockchain in genomics market segmentation (on the basis of application) is further segmented into data sharing and monetization, data storage and security, and automated health insurance.

The global blockchain in genomics market segmentation (on the basis of end user) is further segmented into pharmaceutical and biotechnology companies, hospitals and healthcare providers, research institutes, data owners, and others.

The global blockchain in genomics market segmentation (on the basis of region) is further segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World.

Key Companies in the Global Blockchain in Genomics Market

The key players who have been contributing significantly to the global blockchain in genomics market include Digital DNAtix Ltd., ENCRYPGEN INCORPORATED, Genobank.io Inc., Genomes.io, Longenesis, LunaDNA, LLC, Nebula Genomics, Inc., Shivom Ventures Limited, SimplyVital Health, Inc., WuXi Nextcode Genomics, Inc., and Zenome.io Ltd.

Key Questions Answered in the Report:

Market Overview

The global blockchain in genomic market analysis by BIS Research projects the market to grow at a significant CAGR of 66.42% durin

Download this TOC

Request a Sample

1.1 Research Scope
1.2 Global Blockchain in Genomics Market: Research Methodology
1.2.1 Primary Data Sources
1.2.2 Secondary Data Sources

2.1 Blockchain in Genomics: Decentralizing Data
2.2 Market Definition and Considerations
2.3 Genome Data Sharing on Blockchain
2.4 Classification of Global Blockchain in Genomics Market
2.5 Market Footprint
2.6 Future Potential

3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.3.1 Global Surge in Direct-to-Consumer (DTC) Genetic Testing
3.3.2 Lowering Costs and Increasing Advancement in Sequencing Technologies
3.3.3 Escalating Importance of Bio-Cybersecurity
3.3.4 Nation-Wide Initiatives for Enforcement of Genetic Data Safety
3.4 Market Restraints
3.4.1 Lack of Awareness and Understanding Observed Globally
3.4.2 Massive Carbon Footprint from Energy-Hungry Consensus Mechanisms
3.4.3 Enormous Costs to Maintain Sensitive Genomic Data
3.5 Market Opportunities
3.5.1 Increasing Number of Companies Challenging Patient Data Control Norms
3.5.2 Emergence of Blockchain Consortia
3.5.3 Advancing Precision Medicine with Blockchain-Powered Artificial Intelligence

4.1 Key Strategies and Developments
4.1.1 Synergistic Activities
4.1.2 Product Launches and Enhancements
4.1.3 Business Expansion and Funding Activities
4.1.4 Acquisitions, Approvals, and Others
4.2 Growth Share Analysis, 2018-2029
4.2.1 Growth Share Analysis (by Application), 2018-2029
4.2.2 Growth Share Analysis (by End User), 2018-2029
4.2.3 Growth Share Analysis (by Country), 2018-2029

5.1 Health Insurance Portability and Accountability Act of 1996
5.2 European Union General Data Protection Regulation

6.1 Overview
6.2 B2B Business Model
6.3 B2C Business Model
6.4 C2B Business Model

7.1 Overview
7.2 Utility Tokens
7.3 Blockchain Platforms

8.1 Overview
8.2 Data Sharing and Monetization
8.3 Data Storage and Security
8.4 Automated Health Insurance

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.3 Hospitals and Healthcare Providers
9.4 Research Institutes
9.5 Data Owners
9.6 Other End Users

10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Singapore
10.4.5 Rest-of-Asia-Pacific
10.5 Rest-of-the-World

11.1 Overview
11.2 Digital DNAtix Ltd.
11.2.1 Company Overview
11.2.2 Role of Digital DNAtix Ltd. in the Global Blockchain in Genomics Market
11.2.3 SWOT Analysis
11.3 ENCRYPGEN INCORPORATED
11.3.1 Company Overview
11.3.2 Role of ENCRYPGEN INCORPORATED in the Global Blockchain in Genomics Market
11.3.3 SWOT Analysis
11.4 Genobank.io Inc.
11.4.1 Company Overview
11.4.2 Role of Genobank.io Inc. in the Global Blockchain in Genomics Market
11.4.3 SWOT Analysis
11.5 Genomes.io
11.5.1 Company Overview
11.5.2 Role of Genomes.io in the Global Blockchain in Genomics Market
11.5.3 SWOT Analysis
11.6 Longenesis
11.6.1 Company Overview
11.6.2 Role of Longenesis in the Global Blockchain in Genomics Market
11.6.3 SWOT Analysis
11.7 LunaDNA, LLC
11.7.1 Company Overview
11.7.2 Role of LunaDNA, LLC in the Global Blockchain in Genomics Market
11.7.3 Financials
11.7.4 SWOT Analysis
11.8 Nebula Genomics, Inc.
11.8.1 Company Overview
11.8.2 Role of Nebula Genomics, Inc. in the Global Blockchain in Genomics Market
11.8.3 SWOT Analysis
11.9 Shivom Ventures Limited
11.9.1 Company Overview
11.9.2 Role of Shivom Ventures Limited in the Global Blockchain in Genomics Market
11.9.3 SWOT Analysis
11.10 SimplyVital Health, Inc.
11.10.1 Company Overview
11.10.2 Role of SimplyVital Health, Inc. in the Global Blockchain in Genomics Market
11.10.3 SWOT Analysis
11.11 WuXi Nextcode Genomics, Inc.
11.11.1 Company Overview
11.11.2 Role of WuXi Nextcode Genomics, Inc. in the Global Blockchain in Genomics Market
11.11.3 SWOT Analysis
11.12 Zenome.io Ltd
11.12.1 Company Overview
11.12.2 Role of Zenome.io Ltd in the Global Blockchain in Genomics Market
11.12.3 SWOT Analysis

Table 3.1: Impact Analysis of Market Drivers
Table 3.2: Impact Analysis of Market Restraints

Figure 1: Data Storage on Blockchain
Figure 2: Impact of Market Drivers and Market Restraints on the Global Blockchain in Genomics Market
Figure 3: Global Blockchain in Genomics Market Snapshot
Figure 4: Dominating Segments of the Global Blockchain in Genomics Market, 2018 and 2029
Figure 5: Global Blockchain in Genomics Market (by Business Model), 2018 and 2029
Figure 6: Global Blockchain in Genomics Market (by Service), 2018 and 2029
Figure 7: Global Blockchain in Genomics Market (by Application), 2018 and 2029
Figure 8: Global Blockchain in Genomics Market (by End User), 2018 and 2029
Figure 9: Global Blockchain in Genomics Market (by Region), 2018 and 2029
Figure 1.1: Global Blockchain in Genomics Market Segmentation
Figure 1.2: Global Blockchain in Genomics Market Research Methodology
Figure 1.3: Primary Research
Figure 1.4: Secondary Research
Figure 1.5: Data Triangulation
Figure 1.6: Bottom-up Approach (Segment-wise Analysis)
Figure 1.7: Top-down Approach (Segment-wise Analysis)
Figure 1.8: Assumptions and Limitations
Figure 1.9: Considered Factors for Data Prediction and Modelling
Figure 2.1: Predominant Model of Genome Data Sharing
Figure 2.2: Disruptive Model of Genome Data Sharing
Figure 2.3: Classification of Global Blockchain in Genomics Market
Figure 2.4: Global Blockchain in Genomics Market, 2018-2029
Figure 3.1: Number of People Tested by Consumer Genetics Companies (as of 2019)
Figure 3.2: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 4.1: Share of Key Developments and Strategies, January 2016 – September 2019
Figure 4.2: Synergistic Activities Share (by Company), January 2016 – September 2019
Figure 4.3: Product Launches and Enhancements Share (by Company), January 2016 – September 2019
Figure 4.4: Business Expansion and Funding Activities Share (by Company), January 2016 – September 2019
Figure 4.5: Growth Share Matrix for Global Blockchain in Genomics Market (by Application), 2018-2029
Figure 4.6: Growth Share Matrix for Global Blockchain in Genomics Market (by End User), 2018-2029
Figure 4.7: Growth Share Matrix for Global Blockchain in Genomics Market (by Country), 2018-2029
Figure 6.1: Global Blockchain in Genomics Market (by Business Model)
Figure 6.2: Global Blockchain in Genomics Market (by Business Model), 2018 and 2029
Figure 6.3: Global Blockchain in Genomics Market (by B2B Business Model), 2018-2029
Figure 6.4: Blockchain in Genomics Market (by B2C Business Model), 2018-2029
Figure 6.5: Blockchain in Genomics Market (by C2B Business Model), 2018-2029
Figure 7.1: Global Blockchain in Genomics Market (by Service)
Figure 7.2: Global Blockchain in Genomics Market (by Service), 2018 and 2029
Figure 7.3: Global Blockchain in Genomics Market (Utility Tokens), 2018-2029
Figure 7.4: Blockchain in Genomics Market (Blockchain Platforms), 2018-2029
Figure 7.5: Global Blockchain in Genomics Market (by Blockchain Platform Service), 2018 and 2029
Figure 8.1: Global Blockchain in Genomics Market (by Application)
Figure 8.2: Global Blockchain in Genomics Market (by Application), 2018 and 2029
Figure 8.3: Global Blockchain in Genomics Market (Data Sharing and Monetization), 2018-2029
Figure 8.4: Blockchain in Genomics Market (Data Storage and Security), 2018-2029
Figure 8.5: Blockchain in Genomics Market (Automated Health Insurance), 2018-2029
Figure 9.1: Global Blockchain in Genomics Market (by End User)
Figure 9.2: Global Blockchain in Genomics Market (by End User), 2018 and 2029
Figure 9.3: Global Blockchain in Genomics Market (Pharmaceutical and Biotechnology Companies), 2018-2029
Figure 9.4: Blockchain in Genomics Market (Hospitals and Healthcare Providers), 2018-2029
Figure 9.5: Blockchain in Genomics Market (Research Institutes), 2018-2029
Figure 9.6: Blockchain in Genomics Market (Data Owners), 2018-2029
Figure 9.7: Blockchain in Genomics Market (Other End Users), 2018-2029
Figure 10.1: Global Blockchain in Genomics Market (by Region), 2018 and 2029
Figure 10.2: Global Blockchain in Genomics Market (by Region), 2018 and 2029
Figure 10.3: Global Blockchain in Genomics Market Share (by Region), 2018 and 2029
Figure 10.4: North America Blockchain in Genomics Market, 2018-2029
Figure 10.5: North America: Market Dynamics
Figure 10.6: U.S. Blockchain in Genomics Market, 2018-2029
Figure 10.7: Canada Blockchain in Genomics Market, 2018-2029
Figure 10.8: Europe Blockchain in Genomics Market, 2018-2029
Figure 10.9: Europe: Market Dynamics
Figure 10.10: U.K. Blockchain in Genomics Market, 2018-2029
Figure 10.11: Germany Blockchain in Genomics Market, 2018-2029
Figure 10.12: France Blockchain in Genomics Market, 2018-2029
Figure 10.13: Italy Blockchain in Genomics Market, 2018-2029
Figure 10.14: Spain Blockchain in Genomics Market, 2018-2029
Figure 10.15: Rest-of-Europe Blockchain in Genomics Market, 2018-2029
Figure 10.16: Asia-Pacific Blockchain in Genomics Market, 2018-2029
Figure 10.17: Asia-Pacific: Market Dynamics
Figure 10.18: China Blockchain in Genomics Market, 2018-2029
Figure 10.19: Japan Blockchain in Genomics Market, 2018-2029
Figure 10.20: India Blockchain in Genomics Market, 2018-2029
Figure 10.21: Singapore Blockchain in Genomics Market, 2018-2029
Figure 10.22: Rest-of-Asia-Pacific Blockchain in Genomics Market, 2018-2029
Figure 10.23: Rest-of-the-World Blockchain in Genomics Market, 2018-2029
Figure 11.1: Total Number of Companies Profiled (by Region)
Figure 11.2: Digital DNAtix Ltd.: Overall Product Portfolio
Figure 11.3: Agilent Technologies, Inc.: SWOT Analysis
Figure 11.4: ENCRYPGEN INCORPORATED: Product Portfolio
Figure 11.5: ENCRYPGEN INCORPORATED: SWOT Analysis
Figure 11.6: Genobank.io Inc.: Overall Product Portfolio
Figure 11.7: Genobank.io Inc.: SWOT Analysis
Figure 11.8: Genomes.io: Overall Product Portfolio
Figure 11.9: Genomes.io: SWOT Analysis
Figure 11.10: Longenesis: Overall Product Portfolio
Figure 11.11: Longenesis: SWOT Analysis
Figure 11.12: LunaDNA, LLC: Overall Product Portfolio
Figure 11.13: LunaDNA, LLC: SWOT Analysis
Figure 11.14: Nebula Genomics, Inc.: Overall Product Portfolio
Figure 11.15: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 11.16: Shivom Ventures Limited: Overall Product Portfolio
Figure 11.17: Shivom Ventures Limited: SWOT Analysis
Figure 11.18: SimplyVital Health, Inc.: Overall Product Portfolio
Figure 11.19: SimplyVital Health, Inc.: SWOT Analysis
Figure 11.20: WuXi Nextcode Genomics, Inc.: Overall Product Portfolio
Figure 11.21: WuXi Nextcode Genomics, Inc.: SWOT Analysis
Figure 11.22: Zenome.io Ltd: Overall Product Portfolio
Figure 11.23: Zenome.io Ltd: SWOT Analysis